SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $2.61M invested in Scinai Immunotherapeutics in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$91K
2
+$58K
3
+$55.8K
4
Deutsche Bank
Deutsche Bank
Germany
+$48.1K
5
VIA
Vantage Investment Advisors
Pennsylvania
+$10.8K

Top Sellers

1
-$139K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.92M
2
$200K
3
$192K
4
$113K
5
$91K
6
$58K
7
$13K
8
$8K
9
$5K
10
$1K
11
$1K
12
–